A Comparative Effectiveness Study of Positive Airway Pressure (PAP) Therapy, Dental Device, and Atomoxetine-Oxybutynin for Treatment of Obstructive Sleep Apnea in Adults
NCT07679282 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 2400
Last updated 2026-08-13
Summary
Researchers want to identify which treatments for obstructive sleep apnea (OSA) work best and are easiest for patients to use consistently. Eligible participants will be randomly assigned one of three OSA treatments: traditional PAP therapy, a dental device, or a combination of two FDA-approved medications (atomoxetine and oxybutynin) that are currently approved for other conditions. Over the course of one year, participants will attend two in-person visits and take part in four phone check-ins to complete surveys, report any side effects, and discuss how well they are following their assigned treatment.
Conditions
- Obstructive Sleep Apnea (OSA)
Interventions
- DEVICE
-
Positive airway pressure (PAP) therapy
Positive airway pressure delivered via a nasal or face mask while a patient sleeps to keep the airways open.
- DEVICE
-
Sleep dental device
An oral appliance worn during sleep to move the lower jaw forward, which tightens soft tissues and widens the airway to prevent sleep apnea.
- DRUG
-
Atomoxetine-oxybutynin
The combination of two medications (atomoxetine-oxybutynin) can reduce obstructive sleep apnea by increasing upper airway muscle activity.
Sponsors & Collaborators
- collaborator OTHER
-
Patient-Centered Outcomes Research Institute
collaborator OTHER -
University of Arizona
collaborator OTHER -
University of Maryland
collaborator OTHER -
University of Miami
collaborator OTHER -
Sairam Parthasarathy
lead OTHER
Principal Investigators
-
Sairam Parthasarathy, MD · University of Arizona
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-09-01
- Primary Completion
- 2030-03-01
- Completion
- 2032-05-01
- FDA Drug
- Yes
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea
NCT03189173 ·Status: COMPLETED ·Phase: PHASE2
-
A Novel Pharmacological Therapy for Obstructive Sleep Apnea
NCT03919955 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Upper-Airway Electrical and Pharmacological Stimulation for Obstructive Sleep Apnea
NCT07577661 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Continuation Protocol for Obstructive Sleep Apnea (OSA)
NCT06566820 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Stimulation Therapy for Apnea: Reporting Thoughts
NCT04768543 ·Status: COMPLETED
-
Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea
NCT05944965 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease
NCT00738179 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Different Treatments for Obstructive Sleep Apnea
NCT06352658 ·Status: COMPLETED ·Phase: NA
-
Effects From a Mandibular Repositioning Appliance in Patients With Obstructive Sleep Apnea and Snoring
NCT00477009 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of Customized Adjustable Oral in Treatment of Patients With Obstructive Sleep Apnea Syndrome
NCT03729895 ·Status: UNKNOWN ·Phase: NA
-
TPAP for Comfort in OSA
NCT06264128 ·Status: COMPLETED ·Phase: NA
-
Investigation of a Novel Positive Pressure Therapy to Rescue Patients Failing to Tolerate CPAP During an Initial Encounter
NCT00635206 ·Status: COMPLETED ·Phase: PHASE3
-
TheraPAP Equivalence Crossover Study
NCT06238362 ·Status: COMPLETED ·Phase: NA
-
Positive Pressure Treatment of Obstructive Sleep Apnea
NCT00636181 ·Status: COMPLETED ·Phase: NA
-
Combination Therapy to Treat Sleep Apnea
NCT01633827 ·Status: COMPLETED ·Phase: NA
-
RCT: Oral Appliance Therapy and Sleep Position Trainer in Patients With Position Dependant Obstructive Sleep Apnea
NCT02045576 ·Status: COMPLETED ·Phase: NA
-
Trial on Oral Appliance Design for Improving Upper Airway Function and Sleep Quality
NCT03219034 ·Status: COMPLETED ·Phase: NA
-
Pressure Relief Algorithm Eval
NCT06407999 ·Status: WITHDRAWN ·Phase: NA
-
Reiterative Development and Evaluation Study of OSA Therapy System
NCT01634074 ·Status: UNKNOWN
-
Evaluation of Treatment Efficacy and Comfort of a Modified Positive Airway Pressure Device to Treat Obstructive Sleep Apnea.
NCT02214238 ·Status: COMPLETED ·Phase: NA
-
The Use of Oral Appliances as an Adjunct to Continuous Positive Airway Pressure (CPAP) in the Treatment of Obstructive Sleep Apnoea
NCT00358605 ·Status: COMPLETED ·Phase: NA
-
PAP Therapy Sleep Apnea and Exercise
NCT01786291 ·Status: COMPLETED
-
Snore Positive Airway Pressure Trial
NCT03201055 ·Status: COMPLETED ·Phase: NA
-
Personalised Active Self-management of Sleep Apnea Program
NCT07494292 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Continuous Positive Airway Pressure (PAP) Titration and Treatment Versus Auto-adjusting PAP Treatment for Sleep Apnea
NCT00988351 ·Status: COMPLETED ·Phase: NA